Zenas BioPharma, Inc. (ZBIO) Free cash flow 2023–2025
Zenas BioPharma, Inc. (ZBIO) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$172.4MFY2025 · since FY2023: -$30.5M → -$172.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$172.4M | -43.9% |
| FY2024 | -$119.8M | -292.2% |
| FY2023 | -$30.5M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice
More ZBIO financial trends
ZBIO RevenueZBIO Net incomeZBIO Net marginZBIO Gross profitZBIO Gross marginZBIO Operating incomeZBIO Operating marginZBIO Operating cash flowZBIO Capital expendituresZBIO Return on equityZBIO Stock buybacksZBIO Dividends paidZBIO Total assetsZBIO Total liabilitiesZBIO Shareholders’ equityZBIO overview →